EP2173349
Samsetningar gegn æxlum sem innihalda VEGF hindrandi miðil og írínótekan.
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
2.7.2008EP published:
9.3.2011EP application number:
08827826.2
EP translation filed:
9.6.2011Grant published:
15.7.2011EPO information:
European Patent Register
Max expiry date:
1.7.2028Expiry date:
1.7.2020
Title:
ANTITUMOUR COMBINATIONS CONTAINING A VEGF INHIBITING AGENT AND IRINOTECAN
Timeline
Today
2.7.2008EP application
9.3.2011EP Publication
9.6.2011Translation submitted
15.7.2011Registration published
1.7.2020Expires
Owner
Name:
Aventis Pharma S.A.Address:
20, avenue Raymond Aron, 92160, Antony, FR
Inventor
Name:
BISSERY, Marie-ChristineAddress:
Paris, FR
Name:
CHIRON-BLONDEL, MarielleAddress:
Paris, FR
Name:
LEJEUNE, PascaleAddress:
Paris, FR
Name:
VRIGNAUD, PatriciaAddress:
Paris, FR
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
0704868Date:
5.7.2007Country:
FR
Classification
Categories:
A61K 31/4745, A61K 38/16, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 4
Paid: 8.6.2011
Expires: 2.7.2012
Payer: Sigurjónsson & Thor ehf.
Number: 5
Paid: 7.6.2012
Expires: 2.7.2013
Payer: Sigurjónsson & Thor ehf.
Number: 6
Paid: 6.6.2013
Expires: 2.7.2014
Payer: Árnason Faktor
Number: 7
Paid: 10.6.2014
Expires: 2.7.2015
Payer: Árnason Faktor
Number: 8
Paid: 9.6.2015
Expires: 1.7.2016
Payer: Árnason Faktor
Number: 9
Paid: 8.6.2016
Expires: 1.7.2017
Payer: Árnason Faktor
Number: 10
Paid: 7.6.2017
Expires: 1.7.2018
Payer: Árnason Faktor
Number: 11
Paid: 7.6.2018
Expires: 1.7.2019
Payer: Árnason Faktor
Number: 12
Paid: 5.6.2019
Expires: 1.7.2020
Payer: Árnason Faktor